Biologics represented 5% of the drugs prescribed in the U.S. in 2024, but they accounted for more than half of the country’s ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Every day, millions of Americans depend on prescription drugs for conditions ranging from infections to cancer. Yet, the ...

Shares of Lilly rose as much as 1.7% on Friday, pushing its market value to about $1 trillion, according to data compiled by ...

Oz called the calculation "our estimate based on company numbers," referring to Lilly and Novo Nordisk, the makers of the ...

At a White House event on Nov. 6 announcing price cuts for those blockbuster weight-loss drugs, Medicare and Medicaid Administrator Mehmet Oz made an astonishing claim.

Agency leaders gathered at KPMG’s Leeds offices for Prolific North’s latest From Growth to Gold summit tackling the realities ...

The Trump administration’s tariffs are the talk of the town in Washington. At the end of October, the Senate rejected the ...

In Baltimore, blue collar workers are fighting back, preparing for the “Green Workforce of the Future” and defending offshore ...

The India cefixime market offers growth opportunities driven by increased prevalence of bacterial infections, a strong ...

WASHINGTON (AP) — Unapproved peptide drugs have become a trendy new hack among wellness influencers, fitness coaches and ...

Excerpts from recent editorials in the United States and abroad:___Nov. 17The Wall Street Journal on Trump, Gaza and the U.N. Security CouncilMaybe the United Nations isn’t as useless as it so often ...